$Novavax(NVAX)$WHO webinar starts August 13 13:00 CET:
WHO consultation on COVID-19 vaccines research – 13 August 2021
13 August 2021 13:00 – 18:00 CET
In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&D Blueprint is organizing a consultation on the state of the art and best research methods to evaluate existing, modified and new COVID-19 vaccines.
The objectives of this forthcoming consultation will be to review the available evidence on the efficacy and effectiveness of vaccines being deployed in terms of:
Emerging variants effect on protection levels
Duration of protection
Safety of booster vaccines
Research to evaluate various delivery strategies
https://www.who.int/news-room/events/detail/2021/08/13/default-calendar/who-consultation-on-covid-19-vaccines-research-13-august-2021
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
